Pricing Log in Create free account

InflaRx N.V. (IFRX) vs Larimar Therapeutics, Inc. (LRMR)

InflaRx N.V. and Larimar Therapeutics, Inc. are both Biotechnology companies. InflaRx N.V. and Larimar Therapeutics, Inc. are of similar size ($212.2M and $206.7M). Across the 9 metrics below, InflaRx N.V. leads on 7 and Larimar Therapeutics, Inc. on 2.

Valuation

Metric IFRX LRMR Biotechnology median
P/E n/m n/m 8.50
P/S 5,075.70 n/m 9.71
P/B 0.91 1.62 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.71 n/m 0.64
EV/Sales (1,061.22) n/m 9.21
Earnings yield (43.94%) (97.99%) (33.15%)
Free cash flow yield (17.60%) (75.51%) (25.50%)

Profitability

Metric IFRX LRMR Biotechnology median
Gross margin (26,762.42%) 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (38.71%) (138.41%) (56.36%)
Return on assets (32.75%) (108.53%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IFRX LRMR Biotechnology median
Revenue growth (TTM) (83.39%) — 6.02%
EPS growth (last fiscal year) 9.41% (71.97%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IFRX LRMR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.22 4.70 4.72
Net debt to EBITDA 0.97 0.79 0.96

Dividend

Metric IFRX LRMR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IFRX LRMR Biotechnology median
Market cap 212.21m 206.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack